Fractyl Health, a clinical-stage company developing treatments for obesity and type 2 diabetes, announced that CEO Harith Rajagopalan will participate in several investor conferences from late July to mid-August 2026. These events include the BTIG Virtual Biotechnology Conference, Needham & Company MedTech & Diagnostics Conference, and Canaccord Genuity Growth Conference, featuring one-on-one meetings and a fireside chat. The company is advancing two main therapies, Revita and Rejuva, aimed at addressing metabolic diseases beyond chronic management towards prevention and reversal. Investors can access live webcasts of these presentations on Fractyl's website.
Evercore ISI raised Ross Stores' price target to $276, suggesting a 12.5% upside from its current $245.36 price. The boost reflects strong expectations for Q2, with projected revenues of $6.10 billion (up 10.7%) and earnings per share of $1.92 (up 23...
Nvidia is deepening its involvement in the AI industry by investing $1.5 billion in SB Energy, which is building a major data center campus for OpenAI in Ohio. This deal locks in up to 8 gigawatts of AI computing capacity and ties Nvidia not only as ...
Fabrinet is set to report strong Q3 2026 earnings with revenue forecasted at about $1.276 billion, a 41% increase year-over-year, driven by demand in Telecom and Data Center sectors. Earnings per share are expected to rise 45% to $3.81, reflecting ro...
Micron Technology's stock has soared 240.65% year-to-date in 2026, fueled by a strong AI-driven memory market. The company reported a fiscal Q3 revenue of $41.46 billion and expects fiscal Q4 revenue to reach $50 billion with a non-GAAP EPS of $31. D...
Ana Romero-Davila, platform director at Adient, was honored as a 2026 Automotive News Rising Star, recognizing young U.S. auto industry leaders under 45. She oversees major OEM account launches, strategic planning, and program delivery, recently lead...
